Nordshjaellands Hospital
Hillerød, 3400, Denmark
NCT Number: NCT05970094
The goal of this clinical trial is to learn about and test the effect of an acid/base diet, in chronic kidney patients with CKD stage 4 and 5 in an interventional study with a historical control.
The hypothesize is, that an acid/base diet will reduce the degree of acidosis and the need for oral bicarbonate supplements.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Hillerød, 3400, Denmark
Observational studies indicate that diets with a low "potential renal acid load (PRAL)" is associated with a lower serum-bicarbonate value. The aim is to investigate this association with an interventional studydesign.
Participants will be asked to follow a restricted diet with a low "PRAL" during a 6 week trial divided in three periodes: two week free living control, two week intervention and a two week free living follow-up.
The PRAL calculation tool will be used to create a diet low in acid, based on this the patients will receive individual diet plans. The diet will comply with national treshold guidelines for potassium and protein, this is due to the high risk of hyperkalemia in patients with chronic kidney disease. The patients will be asked to document their food and drink intake by taking pictures of their plates and cups before and after a meal, over a 24 hour period.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Two weeks on a low PRAL diet compared to 2 week free living
Time frame: 6 weeks
mmol/l
Time frame: 6 weeks
U/l
Time frame: 6 weeks
mmol/l
Time frame: 6 weeks
umol/l
Time frame: 6 weeks
pmol/l
Time frame: 6 weeks
mmol/l
Time frame: 6 weeks
g/l
Time frame: 6 weeks
mmol/d
Time frame: 6 weeks
mmol/d
Time frame: 6 weeks
mmol/d
Time frame: 6 weeks
mmol/d
Time frame: 6 weeks
mg/d
Time frame: 6 weeks
mmol/d
Time frame: 6 weeks
mmol/d
Time frame: 6 weeks
mmol/d
Time frame: 6 weeks
meqv/day
Time frame: 6 weeks
Units
Time frame: 6 weeks
mmol/day
Time frame: 6 weeks
meqv/day
Time frame: 6 weeks
mmol/l
Time frame: 6 weeks
mmol/l
Time frame: 6 weeks
mmol/l
Time frame: 6 weeks
mmol/l
Time frame: 6 weeks
mmol/l
University of Copenhagen
Other
Acronym: REMA-CKD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04876963
Arrhythmias, Cardiac, Cardiovascular Diseases
Copenhagen, Denmark
View Trial DetailsNCT05624710
Chronic Disease, Disease Attributes
Tustin, California, United States
View Trial DetailsNCT04193865
Acute Injury of Kidney, Acute Kidney Injury
Charleston, South Carolina, United States
View Trial DetailsNCT05624723
Chronic Disease, Disease Attributes
Orlando, Florida, United States
View Trial Details